Status:

COMPLETED

The Effect of Eyemasks on Neonatal Stress Following Dilated Retinal Examination

Lead Sponsor:

Sunnybrook Health Sciences Centre

Collaborating Sponsors:

Unity Health Toronto

Conditions:

Retinopathy of Prematurity

Pain

Eligibility:

All Genders

Phase:

NA

Brief Summary

Although screening exams for retinopathy of prematurity (ROP) prevent blindness they are physiologically stressful for infants. The investigators postulate that photosensitivity during mydriasis contr...

Detailed Description

Retinopathy of Prematurity (ROP) is a disorder of retinal vascular development of the low birthweight preterm infant that may lead to blindness if untreated. The long term visual acuity of infants wit...

Eligibility Criteria

Inclusion

  • Infant with birthweight of ≤1500 g or less or a gestational age of ≤ 32 weeks with no prior ROP screening. Examinations will be performed starting at either 4 weeks chronological age or 31 weeks post menstrual age, whichever is later.

Exclusion

  • Pre-existing corneal abrasion/ulcers, ocular malformations that prevent dilation, and known neurological abnormalities that could affect response to pain.
  • Anticipation of transfer to another institution.
  • Prior ROP screening

Key Trial Info

Start Date :

April 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2017

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT03824782

Start Date

April 1 2016

End Date

June 30 2017

Last Update

January 31 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada